REQUEST A DEMO
Total
USD $0.00
Search more companies

Meribank Biotech Co., Ltd. (宣捷干细胞生技股份有限公司) (Taiwan, China)

Main Activities: Professional, Scientific, and Technical Services
Full name: Meribank Biotech Co., Ltd. Profile Updated: February 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Meribank Biotech Co., Ltd. (宣捷干细胞生技股份有限公司) is based in Taiwan, China, with the head office in Taipei City. It operates in the Professional, Scientific, and Technical Services sector. It was incorporated on February 13, 2001. The total number of employees is currently 140 (2023). There was a net sales revenue increase of 92.14% reported in Meribank Biotech Co., Ltd. (宣捷干细胞生技股份有限公司)’s latest financial highlights for Q2C2025. During that time, Meribank Biotech Co., Ltd. (宣捷干细胞生技股份有限公司)’s total assets grew by 131.89%. The net profit margin of Meribank Biotech Co., Ltd. (宣捷干细胞生技股份有限公司) increased by 29.36% in 2025.

Headquarters
1F., No.68, Sec. 1, Neihu Rd, Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Meribank Biotech Co., Ltd. (宣捷干细胞生技股份有限公司) report to view the information.

Website: http://www.meribank.com.tw

Basic Information
Total Employees:
Purchase the Meribank Biotech Co., Ltd. (宣捷干细胞生技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Meribank Biotech Co., Ltd. (宣捷干细胞生技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Meribank Biotech Co., Ltd. (宣捷干细胞生技股份有限公司) report to view the information.
Incorporation Date:
February 13, 2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
16.68%
Purchase this report to view the information.
6.09%
Purchase this report to view the information.
1.83%
Purchase this report to view the information.
1.45%
Purchase this report to view the information.
1.33%
Subsidiaries
育禾管理顧問股份有限公司
99%
堂庭檢驗科技股份有限公司(堂庭檢驗)
82%
智捷生醫股份有限公司
12.88%
Company Performance
Financial values in the chart are available after Meribank Biotech Co., Ltd. (宣捷干细胞生技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
92.14%
Total Operating Revenue
95.23%
Operating Profit
79.74%
EBITDA
N/A
Net Profit/Loss for the Period
59.97%
Total Assets
131.89%
Total Equity
95.8%
Operating Profit Margin
33.38%
Net Profit Margin
29.36%
Return on Equity (ROE)
6.22%
Debt / Equity
54583%
Quick Ratio
-1067.72%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?